A NOVEL PHASE II TRIAL OF IPILIMUMAB, CARBOPLATIN AND ETOPOSIDE (ICE) FOR THE FIRST LINE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG CANCER (SCLC)

被引：2
|
作者：
Ottensmeier, C. [1 ]
Galea, I. [2 ]
Cross, N. [3 ]
Maishman, T. [3 ]
Hamid, D. [3 ]
Cave, J. [4 ]
Wheater, M. [5 ]
Geldart, T. [6 ]
Mulatero, C. [7 ]
Potter, V. [8 ]
Danson, S. [9 ]
Woll, P. [10 ]
Griffiths, R. [11 ]
Nolan, L. [5 ]
机构：
[1] Southampton Univ Hosp NHS Trust, Canc Sci Div, Southampton, Hants, England
[2] Univ Hosp Southampton NHS Fdn Trust, Wessex Neurosci Ctr, Southampton, Hants, England
[3] Univ Southampton, Clin Trials Unit, Southampton, Hants, England
[4] Univ Hosp Southampton NHS FoundationTrust, Dept Med Oncol, Southampton, Hants, England
[5] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[6] Royal Bournemouth Hosp, Bournemouth, Dorset, England
[7] Leeds Teaching Hosp NHS Trust, St James Univ Hosp, Leeds, W Yorkshire, England
[8] Nottingham Univ Hosp NHS Trust, Dept Oncol, Nottingham, England
[9] Weston Pk Hosp, Canc Res Ctr, Acad Unit Clin Oncol, Sheffield, S Yorkshire, England
[10] Weston Pk Hosp, Canc Res Ctr, Dept Oncol, Sheffield, S Yorkshire, England
[11] Clatterbridge Canc Ctr, Wirral, Merseyside, England
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu355.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1477P
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety analysis of anlotinib combined with etoposide plus cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (SCLC): The final results from a phase II single-arm trial.
    Kong, Tiandong
    Chen, Lu
    Duan, Fangfang
    Hou, Xiaoxia
    Wang, Liuyan
    Zhou, Hanli
    Wang, Lanrong
    Hu, Shanshan
    Liu, Danna
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer
    Horn, Leora
    Zhao, Zhiguo
    Sandler, Alan
    Johnson, David
    Shyr, Yu
    Wolff, Steven
    DeVore, Russell F.
    Laskin, Janessa
    CLINICAL LUNG CANCER, 2011, 12 (03) : 161 - 165
  • [43] A PHASE-II TRIAL OF CARBOPLATIN IN UNTREATED PATIENTS WITH EXTENSIVE STAGE SMALL-CELL LUNG-CANCER
    PALLARES, C
    IZQUIERDO, MA
    PAREDES, A
    SAGARRA, AF
    DEANDRES, L
    LOPEZ, JJL
    CANCER, 1991, 68 (01) : 40 - 43
  • [44] Randomized phase II trial of pemetrexed with either cisplatin or carboplatin in extensive stage small cell lung cancer.
    Socinski, MA
    Weissman, C
    Hart, LL
    Choksi, JK
    Holladay, C
    Prager, D
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
  • [45] Phase II trial of ipilimumab (IPI) and paclitaxel/carboplatin (P/C) in first-line stage IIIb/IV non-small cell lung cancer (NSCLC).
    Lynch, T. J.
    Bondarenko, I. N.
    Luft, A.
    Serwatowski, P.
    Barlesi, F.
    Chacko, R. T.
    Sebastian, M.
    Siegel, J.
    Cuillerot, J.
    Reck, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] EQ-5D UTILITY ESTIMATES FROM THE CASPIAN TRIAL OF DURVALUMAB plus CARBOPLATIN/CISPLATIN plus ETOPOSIDE VS. CARBOPLATIN/CISPLATIN plus ETOPOSIDE IN FIRST LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
    Johal, S.
    Fischer, C.
    Genestier, V
    Brannman, L.
    VALUE IN HEALTH, 2022, 25 (01) : S210 - S210
  • [47] A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer CALGB 30104
    Govindan, Ramaswamy
    Wang, Xiaofei
    Baggstrom, Maria Q.
    Burdette-Radoux, Susan
    Hodgson, Lydia
    Vokes, Everett E.
    Green, Mark R.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 220 - 226
  • [48] Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer
    Chen, Gigi
    Huynh, Minh
    Fehrenbacher, Lou
    West, Howard
    Lara, Primo N., Jr.
    Yavorkovsky, Leonid L.
    Russin, Michael
    Goldstein, Desiree
    Gandara, David
    Lau, Derick
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) : 1401 - 1404
  • [49] Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer
    Yoichi Nakanishi
    Yuji Kawarada
    Nobuyuki Hirose
    Kiyoshi Ninomiya
    Masayuki Miyazaki
    Naoki Miyazaki
    Yukio Kurita
    Hideaki Kanegae
    Osamu Ohgushi
    Kenichi Ogata
    Hiroshi Yamazaki
    Satoru Inutsuka
    Nobuyuki Hara
    Cancer Chemotherapy and Pharmacology, 1998, 41 : 453 - 456
  • [50] Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer
    Nakanishi, Y
    Kawarada, Y
    Hirose, N
    Ninomiya, K
    Miyazaki, M
    Miyazaki, N
    Kurita, Y
    Kanegae, H
    Ohgushi, O
    Ogata, K
    Yamazaki, H
    Inutsuka, S
    Hara, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (06) : 453 - 456
12345